Minerva Neurosciences NERV
NASDAQ NERV
$2.56 +0.07 (+2.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Minerva Neurosciences (NERV) Price to Earnings (2020 - 2025)

Updated

Minerva Neurosciences' Price to Earnings was 1.07 in Q2 2025, down 43.6% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Price to Earnings (2020 - 2025) Analysis & Trends

For FY2024, Price to Earnings at Minerva Neurosciences came in at 10.79.

  • In earlier years, Price to Earnings was 51.51 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Minerva Neurosciences 124.09 Mn -188.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.07
Mar 31, 2025 1.90
Dec 31, 2024 10.79
Mar 31, 2021 23.59
Dec 31, 2020 51.49
API Access

Minerva Neurosciences Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=NERV&period=max&api_key=YOUR_API_KEY